Clinical Trial Update: Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2) [Phase 3]

View source ↗

Summary

Phase 3 DELTA 2 trial evaluates the efficacy and safety of delgocitinib cream in adults with moderate-to-severe chronic hand eczema. The study has completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Eczema

Drugs mentioned

• Delgocitinib Cream (delgocitinib)

Snippet

Sponsor: LEO Pharma | Conditions: Chronic Hand Eczema | Phase 3 | Status: COMPLETED | Results posted: 2024-10-17